Treatment of chronic hepatitis B naïve patients with a therapeutic vaccine containing HBs and HBc antigens (a randomized, open and treatment controlled phase III clinical trial)Mamun Al Mahtab, Morikazu Onji, E Penton et al.|PLoS ONE|2018Cited by 94
Intranasal therapeutic vaccine containing HBsAg and HBcAg for patients with chronic hepatitis B; 18 months follow‐up results of phase IIa clinical studyOsamu Yoshida, Yoichi Hiasa, Sheikh Mohammad Fazle Akbar et al.|Hepatology Research|2022Cited by 24